QM/MM As a Tool in Fragment Based Drug Discovery. A Cross-Docking, Rescoring Study of Kinase Inhibitors

被引:44
作者
Gleeson, M. Paul [1 ]
Gleeson, Duangkamol [2 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] King Mongkuts Inst Technol Ladkrabang, Dept Chem, Fac Sci, Bangkok 10520, Thailand
关键词
MOLECULAR-MECHANICS; BINDING-AFFINITY; FORCE-FIELD; CRYSTALLOGRAPHY; VALIDATION; ADSORPTION; SIMULATION; PREDICTION; DYNAMICS; LIGANDS;
D O I
10.1021/ci900022h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of QM/MM based methods to optimize and rescore GOLD derived cross-docked protein-ligand poses has been investigated using a range of fragment-like kinase inhibitors where experimental data have been reported. Particular emphasis has been placed on rationalizing the potential benefits of the method in the increasingly popular fragment based drug discovery area. The results of this cross-docking, rescoring study on 9 protein ligand complexes suggest that the hybrid QM/MM calculations could prove useful in kinase fragment based drug discovery (FBDD). B3LYP/6-31G**//UFF derived enthalphies allow us to identify the correct X-ray pose from a range of plausible decoys 77% of the time, almost a doubling of the retrieval rate compared to GOLD (44%). In addition, this method provides us with a means to rapidly and accurately generate virtual protein-ligand complexes that will allow a program team to probe the existing interactions between the ligand and protein and search for additional interactions.
引用
收藏
页码:1437 / 1448
页数:12
相关论文
共 52 条
[31]   All-atom empirical potential for molecular modeling and dynamics studies of proteins [J].
MacKerell, AD ;
Bashford, D ;
Bellott, M ;
Dunbrack, RL ;
Evanseck, JD ;
Field, MJ ;
Fischer, S ;
Gao, J ;
Guo, H ;
Ha, S ;
Joseph-McCarthy, D ;
Kuchnir, L ;
Kuczera, K ;
Lau, FTK ;
Mattos, C ;
Michnick, S ;
Ngo, T ;
Nguyen, DT ;
Prodhom, B ;
Reiher, WE ;
Roux, B ;
Schlenkrich, M ;
Smith, JC ;
Stote, R ;
Straub, J ;
Watanabe, M ;
Wiórkiewicz-Kuczera, J ;
Yin, D ;
Karplus, M .
JOURNAL OF PHYSICAL CHEMISTRY B, 1998, 102 (18) :3586-3616
[32]   The protein kinase complement of the human genome [J].
Manning, G ;
Whyte, DB ;
Martinez, R ;
Hunter, T ;
Sudarsanam, S .
SCIENCE, 2002, 298 (5600) :1912-+
[33]   Optimizing fragment and scaffold docking by use of molecular interaction fingerprints [J].
Marcou, Gilles ;
Rognan, Didier .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (01) :195-207
[34]   Automated protein-ligand crystallography for structure-based drug design [J].
Mooij, Wijnand T. M. ;
Hartshorn, Michael J. ;
Tickle, Ian J. ;
Sharff, Andrew J. ;
Verdonk, Marcel L. ;
Jhoti, Harren .
CHEMMEDCHEM, 2006, 1 (08) :827-838
[35]   Application of ONIOM calculations in the study of the effect of the zeolite framework on the adsorption of alkenes to ZSM-5 [J].
Namuangruk, Supawadee ;
Tantanak, Duangkamol ;
Limtrakul, Jumras .
JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL, 2006, 256 (1-2) :113-121
[36]   Structures and reaction mechanisms of propene oxide isomerization on H-ZSM-5: An ONIOM study [J].
Namuangruk, Supawadee ;
Khongpracha, Pipat ;
Pantu, Piboon ;
Limtrakul, Jumras .
JOURNAL OF PHYSICAL CHEMISTRY B, 2006, 110 (51) :25950-25957
[37]   Large-scale validation of a quantum mechanics based scoring function: Predicting the binding affinity and the binding mode of a diverse set of protein-ligand complexes [J].
Raha, K ;
Merz, KM .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (14) :4558-4575
[38]   The role of quantum mechanics in structure-based drug design [J].
Raha, Kaushik ;
Peters, Martin B. ;
Wang, Bing ;
Yu, Ning ;
WollaCott, Andrew M. ;
Westerhoff, Lance M. ;
Merz, Kenneth M., Jr. .
DRUG DISCOVERY TODAY, 2007, 12 (17-18) :725-731
[39]   UFF, A FULL PERIODIC-TABLE FORCE-FIELD FOR MOLECULAR MECHANICS AND MOLECULAR-DYNAMICS SIMULATIONS [J].
RAPPE, AK ;
CASEWIT, CJ ;
COLWELL, KS ;
GODDARD, WA ;
SKIFF, WM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (25) :10024-10035
[40]  
*RCSB, 28 RCSB PROT DAT